Clover Health Investments, Corp. (CLOV)
NASDAQ: CLOV · Real-Time Price · USD
4.460
-0.080 (-1.76%)
At close: Sep 18, 2026, 4:00 PM EDT
4.470
+0.010 (0.22%)
After-hours: Sep 18, 2026, 7:54 PM EDT
Clover Health Investments Stock Forecast
Stock Price Forecast
According to 4 analysts polled by S&P Global, Clover Health Investments stock has a consensus rating of "Buy" and an average price target of $5.38. The average 1-year stock price forecast is 20.63% higher than the current stock price, while the lowest is $5.00 (+12.11%) and the highest is $6.00 (+34.53%).
Price Target: $5.38 (+20.63%)
Analyst Consensus: Buy
Price Target
ChartAnalyst Ratings
The average analyst rating for Clover Health Investments stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Mar '26 | May '26 | Jun '26 | Jul '26 | Aug '26 | Sep '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 1 | 1 | 1 | 1 | 1 | 2 |
| Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Hold | 2 | 2 | 2 | 2 | 2 | 2 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 3 | 3 | 3 | 3 | 3 | 4 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Deutsche Bank | Deutsche Bank | Buy Initiates $6 | Buy | Initiates | $6 | +34.53% | Sep 10, 2026 |
| Canaccord Genuity | Canaccord Genuity | Buy Maintains $5.5 | Buy | Maintains | $5.5 | +23.32% | Aug 12, 2026 |
| UBS | UBS | Hold Maintains $4.75 → $5 | Hold | Maintains | $4.75 → $5 | +12.11% | Aug 6, 2026 |
Financial Forecast
Revenue This Year
2.95B
from 1.92B
Increased by 53.58%
Revenue Next Year
3.53B
from 2.95B
Increased by 19.34%
EPS This Year
0.10
from 0.04
Increased by 155.44%
EPS Next Year
0.16
from 0.10
Increased by 59.01%
EPS and Forward PE are based on non-GAAP adjusted numbers.